- Home
- EXEL vs PAC Comparison
EXEL vs PAC Comparison
Compare EXEL & PAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- PAC
- Stock Information
- Founded
- EXEL 1994
- PAC 1998
- Country
- EXEL United States
- PAC Mexico
- Employees
- EXEL N/A
- PAC N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- PAC Aerospace
- Sector
- EXEL Health Care
- PAC Consumer Discretionary
- Exchange
- EXEL Nasdaq
- PAC Nasdaq
- Market Cap
- EXEL 9.8B
- PAC 10.4B
- IPO Year
- EXEL 2000
- PAC 2006
- Fundamental
- Price
- EXEL $43.04
- PAC $230.35
- Analyst Decision
- EXEL Buy
- PAC Buy
- Analyst Count
- EXEL 18
- PAC 6
- Target Price
- EXEL $38.76
- PAC $207.50
- AVG Volume (30 Days)
- EXEL 3.9M
- PAC 82.2K
- Earning Date
- EXEL 05-13-2025
- PAC 07-22-2025
- Dividend Yield
- EXEL N/A
- PAC 3.35%
- EPS Growth
- EXEL 237.58
- PAC N/A
- EPS
- EXEL 2.20
- PAC 0.86
- Revenue
- EXEL $2,298,922,000.00
- PAC $1,435,598,195.00
- Revenue This Year
- EXEL $10.39
- PAC $57.91
- Revenue Next Year
- EXEL $10.74
- PAC $8.28
- P/E Ratio
- EXEL $19.53
- PAC $26.60
- Revenue Growth
- EXEL 24.49
- PAC 14.67
- 52 Week Low
- EXEL $20.40
- PAC $146.62
- 52 Week High
- EXEL $48.85
- PAC $234.21
- Technical
- Relative Strength Index (RSI)
- EXEL 59.93
- PAC 62.01
- Support Level
- EXEL $42.21
- PAC $223.43
- Resistance Level
- EXEL $43.75
- PAC $231.21
- Average True Range (ATR)
- EXEL 1.60
- PAC 5.62
- MACD
- EXEL -0.09
- PAC -0.41
- Stochastic Oscillator
- EXEL 53.96
- PAC 70.12
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About PAC Grupo Aeroportuario Del Pacifico S.A. B. de C.V. Grupo Aeroportuario Del Pacifico S.A. de C.V. (each representing 10 Series B shares)
Grupo Aeroportuario del Pacifico SAB de CV is engaged in the construction, development, and operation of airports in Mexico. The company's segment includes Guadalajara; Tijuana; Puerto Vallarta; San Jose del Cabo; Montego Bay; Hermosillo; Guanajuato and Other Airports. It generates maximum revenue from the Guadalajara segment.